Peripheral Vascular Devices Market: Size, Trends, and Growth Outlook
The global peripheral vascular devices market is witnessing robust growth as the burden of cardiovascular and circulatory conditions continues to rise worldwide. According to Fortune Business Insight, the global peripheral vascular devices market size was valued at USD 12.04 billion in 2025 and is projected to grow from USD 12.62 billion in 2026 to USD 19.42 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period. North America dominated the global market with a share of 40.78% in 2025.
Peripheral vascular devices are specialized medical tools used to open or restore blood flow in vessels located outside the heart, particularly in the arms and legs. These devices become essential when blood vessels narrow or become blocked, a condition that can cause pain while walking, delay wound healing, and in severe cases, lead to a risk of limb loss. As healthcare systems across the globe grapple with rising rates of diabetes and lifestyle-related diseases, the demand for effective, minimally invasive solutions to treat vascular conditions has never been greater.
Market Drivers
One of the strongest forces propelling this market forward is the increasing burden of peripheral artery disease (PAD). According to Fortune Business Insight, an estimated 236 million adults worldwide were suffering from peripheral artery disease as of June 2021. This growing patient pool, combined with lifestyle changes and a rising occurrence of blood-circulation conditions, is pushing hospitals to adopt newer tools capable of improving outcomes and reducing the need for repeat procedures. As a result, companies within the space are actively pursuing new product clearances and portfolio expansions to meet this surging demand.
Hospitals also increasingly prefer treatments that shorten recovery times, which has made minimally invasive procedures far more common than traditional open surgeries. This shift benefits both clinicians and patients, supporting higher procedure volumes and repeat use of peripheral vascular devices. As hospitals continue to expand their cath labs and endovascular suites, the demand for a broader range of peripheral vascular devices is expected to rise correspondingly.
Technological advancement is another critical growth lever. For instance, in April 2024, Abbott received FDA approval for its Esprit BTK Everolimus eluting resorbable scaffold system, a device designed specifically for blood flow regulation in the lower leg. Similarly, in January 2024, Reflow Medical received CE approval for its Spur peripheral retrievable stent system, introduced for the treatment of complex peripheral arterial disease, including below-the-knee vessels. Such approvals are giving hospitals greater confidence to treat increasingly complex cases earlier and more effectively.
Market Restraints and Challenges
Despite this positive trajectory, the market faces notable headwinds. Peripheral vascular devices are subject to strong regulatory scrutiny since they are used within critical blood vessels, and hospitals demand clear proof of safety and clinical benefit before switching to newer products. This caution slows adoption rates, increases the burden of clinical study requirements, and can delay product launches across different countries. Even devices already in widespread use must continually respond to ongoing safety monitoring and evolving regulatory updates.
Pricing pressure represents another significant challenge, particularly in hospital settings that procure devices through tenders or group purchasing organizations. When hospitals evaluate multiple similar devices, price often becomes the deciding factor, which can compress manufacturer margins and reduce willingness to invest heavily in sales support. This dynamic has led to longer negotiation cycles, with companies increasingly offering discounts, bundled pricing, or extended service terms to secure contracts.
Segmentation Insights
By product, the market is segmented into vascular access & entry devices, vascular navigation & delivery devices, intravascular diagnostic & imaging devices, thrombus & embolus management devices, peripheral stents, and others. According to Fortune Business Insight, the peripheral stent segment is anticipated to account for the largest market share, owing to superior treatment outcomes and applicability across a wide range of patient severity levels. Meanwhile, the thrombus & embolus management devices segment is anticipated to rise at a CAGR of 6.6% over the forecast period.
By application, the market is divided into peripheral arterial disorders, aneurysmal disease, venous diseases, and others, with peripheral arterial disorders dominating in 2025 due to the widespread prevalence of PAD globally.
By end-user, hospitals held the highest market share in 2025 and, according to Fortune Business Insight, are set to hold a 61.8% share in 2026, as most procedures require imaging support, specialist teams, and post-procedure monitoring. Specialty clinics, meanwhile, are projected to grow at a CAGR of 5.8% during the study period.
Regional Outlook
North America maintained its market leadership, with the region valued at USD 4.91 billion in 2026, according to Fortune Business Insight. The U.S. market alone is estimated at around USD 4.39 billion in 2026, representing roughly 34.8% of global sales.
Europe is projected to reach a valuation of USD 3.41 billion by 2026, supported by a 5.0% growth rate, driven by rising investments in new product development and a growing incidence of venous disease. Germany’s market is projected to reach approximately USD 0.77 billion in 2026, while the U.K. market is estimated at around USD 0.55 billion.
Asia Pacific is estimated to reach USD 2.87 billion in 2026, securing its position as the third-largest regional market, supported by improving healthcare infrastructure and favorable reimbursement policies. China’s market is projected to be among the largest worldwide, with 2026 revenues estimated at around USD 0.95 billion, while India’s market is estimated at around USD 0.64 billion.
Competitive Landscape
The global peripheral vascular devices market holds a semi-consolidated structure, with prominent players including Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, and BD. According to Fortune Business Insight, these companies command significant market share due to extensive strategic activities, including substantial investments and frequent product approvals. Other notable participants include Cook Medical, Cardinal Health, Teleflex Incorporated, Merit Medical Systems, and Getinge, with collaborations expected to be a key strategic focus going forward.
Conclusion
The peripheral vascular devices market stands at an important juncture, buoyed by rising disease prevalence, a clear shift toward minimally invasive care, and continuous technological innovation. While pricing pressures and regulatory scrutiny remain persistent challenges, the overall growth trajectory through 2034 reflects strong, sustained demand across hospitals and specialty clinics worldwide.
What’s Driving Japan’s Market? Discover the Latest “Peripheral Vascular Devices” Insights